OBJECTIVES/HYPOTHESIS: To evaluate the efficacy of photodynamic therapy (PDT) with the phthalocyanine photosensitizer Pc 4 for treating an animal model of recurrent respiratory papillomatosis (RRP). METHODS: Rabbit skin was grafted onto the dorsum of severe combined immunodeficient mice, two xenografts per animal. After the graft healed, it was inoculated with cottontail rabbit papillomavirus (CRPV). When papillomas developed, Pc 4 (0.6 or 1.0 mg/kg) was administered systemically, and 48 hours later, one papilloma of the two on each animal was exposed to 675-nm photoactivating light at either 100 or 150 J/cm(2). In addition to the contralateral tumors, which received Pc 4 but no light, other controls included animals receiving light only or neither agent. Response was assessed by measuring papilloma size with a caliper. Some papillomas and residual skin were harvested for histological assessment. RESULTS: For the lower-dose PDT regimens, papilloma growth rates were not significantly different from the controls. In contrast, 13 of 15 papillomas receiving the higher Pc 4 dose (1.0 mg/kg) and the higher light fluence (150 J/cm(2)) regressed completely and did not regrow within the observation period of up to 79 days. The response of these papillomas was significantly different from the controls (P < .001). Histological analysis confirmed the absence of residual tumor following complete response and replacement with near-normal epithelium. CONCLUSIONS: Pc 4-PDT is highly effective in treating virally induced (CRPV) papillomas in a murine model of RRP, and thus warrants further study as a treatment for HPV-induced papillomas.
OBJECTIVES/HYPOTHESIS: To evaluate the efficacy of photodynamic therapy (PDT) with the phthalocyanine photosensitizer Pc 4 for treating an animal model of recurrent respiratory papillomatosis (RRP). METHODS:Rabbit skin was grafted onto the dorsum of severe combined immunodeficientmice, two xenografts per animal. After the graft healed, it was inoculated with cottontail rabbit papillomavirus (CRPV). When papillomas developed, Pc 4 (0.6 or 1.0 mg/kg) was administered systemically, and 48 hours later, one papilloma of the two on each animal was exposed to 675-nm photoactivating light at either 100 or 150 J/cm(2). In addition to the contralateral tumors, which received Pc 4 but no light, other controls included animals receiving light only or neither agent. Response was assessed by measuring papilloma size with a caliper. Some papillomas and residual skin were harvested for histological assessment. RESULTS: For the lower-dose PDT regimens, papilloma growth rates were not significantly different from the controls. In contrast, 13 of 15 papillomas receiving the higher Pc 4 dose (1.0 mg/kg) and the higher light fluence (150 J/cm(2)) regressed completely and did not regrow within the observation period of up to 79 days. The response of these papillomas was significantly different from the controls (P < .001). Histological analysis confirmed the absence of residual tumor following complete response and replacement with near-normal epithelium. CONCLUSIONS:Pc 4-PDT is highly effective in treating virally induced (CRPV) papillomas in a murine model of RRP, and thus warrants further study as a treatment for HPV-induced papillomas.
Authors: John E George; Yusra Ahmad; Davood Varghai; Xiaolin Li; Jeffrey Berlin; David Jackowe; Marc Jungermann; Michael S Wolfe; Lothar Lilge; Ali Totonchi; Rachel L Morris; Allyn Peterson; W David Lust; Malcolm E Kenney; Charles L Hoppel; Jiayang Sun; Nancy L Oleinick; David Dean Journal: Lasers Surg Med Date: 2005-06 Impact factor: 4.025
Authors: C M Whitacre; D K Feyes; T Satoh; J Grossmann; J W Mulvihill; H Mukhtar; N L Oleinick Journal: Clin Cancer Res Date: 2000-05 Impact factor: 12.531
Authors: C A Megerian; S I Zaidi; R C Sprecher; S Setrakian; D W Stepnick; N L Oleinick; H Mukhtar Journal: Laryngoscope Date: 1993-09 Impact factor: 3.325
Authors: T Glanzmann; C Hadjur; M Zellweger; P Grosiean; M Forrer; J P Ballini; P Monnier; H van den Bergh; C K Lim; G Wagnières Journal: Photochem Photobiol Date: 1998-05 Impact factor: 3.421
Authors: Ken Kang-Hsin Wang; Jeremy D Wilson; Malcolm E Kenney; Soumya Mitra; Thomas H Foster Journal: Photochem Photobiol Date: 2007 Sep-Oct Impact factor: 3.421
Authors: Alyssa Master; Anthony Malamas; Rachna Solanki; Dana M Clausen; Julie L Eiseman; Anirban Sen Gupta Journal: Mol Pharm Date: 2013-04-24 Impact factor: 4.939